EricHansonMD
Pediatric Rheumatology • Indianapolis, INExecutive Director, Immunology Clinical Services, Eli Lilly & Co.
Dr. Hanson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Lilly Corporate Center
893 S. Delaware Avenue
Indianapolis, IN 46285Phone+1 317-460-4636
Summary
- Early phase drug development in immune-mediated diseases
Education & Training
Children's Hospital of PhiladelphiaFellowship, Pediatric Rheumatology, 2005 - 2009
Tower Health/St. Christopher's Hospital for ChildrenResidency, Pediatrics, 2002 - 2005
University of Pittsburgh School of MedicineClass of 2002
Certifications & Licensure
IN State Medical License 2019 - 2025
PA State Medical License 2005 - 2021- American Board of Pediatrics Pediatric Rheumatology
Publications & Presentations
PubMed
- 126 citationsDistinct interferon signatures and cytokine patterns define additional systemic autoinflammatory diseasesAdriana Almeida de Jesus, Yangfeng Hou, Stephen R. Brooks, Louise Malle, Angelique Biancotto
The Journal of Clinical Investigation. 2020-04-01 - 167 citationsHypomorphic nuclear factor-κB essential modulator mutation database and reconstitution system identifies phenotypic and immunologic diversityEric P. Hanson, Linda Monaco-Shawver, Laura A. Solt, Lisa A. Madge, Pinaki P. Banerjee
The Journal of Allergy and Clinical Immunology. 2008-12-01 - 389 citationsLoss-of-function mutations in TNFAIP3 leading to A20 haploinsufficiency cause an early-onset autoinflammatory diseaseQing Zhou, Hongying Wang, Daniella M. Schwartz, Monique Stoffels, Yong Hwan Park
Nature Genetics. 2016-01-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
